Jove
Visualize
Contact Us

Related Experiment Videos

Xeroderma pigmentosum-Cockayne syndrome complex.

Valerie Natale1, Hayley Raquer2

  • 1Forgotten Diseases Research Foundation, Santa Clara, CA, 95050, USA. vnatale@forgottendiseases.org.

Orphanet Journal of Rare Diseases
|April 6, 2017
PubMed
Summary

Xeroderma pigmentosum-Cockayne syndrome complex (XP-CS) is a rare disorder. This study compiles clinical data, revealing similarities to Cockayne syndrome but with notable differences in cancer incidence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia.

The Journal of allergy and clinical immunology·2024
Same author

Transcriptional profiling of peripheral blood mononuclear cells identifies inflammatory phenotypes in Ataxia Telangiectasia.

Orphanet journal of rare diseases·2024
Same author

Worldwide variation in human growth and the World Health Organization growth standards: a systematic review.

BMJ open·2014
Same author

A comprehensive description of the severity groups in Cockayne syndrome.

American journal of medical genetics. Part A·2011
Same author

H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks.

Proceedings of the National Academy of Sciences of the United States of America·2006
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Genetics and rare diseases
  • Molecular biology
  • Clinical genetics

Background:

  • Xeroderma pigmentosum-Cockayne syndrome complex (XP-CS) is a rare multisystem degenerative disorder.
  • Existing literature on XP-CS is fragmented, necessitating a consolidated clinical overview.
  • Understanding XP-CS is crucial for managing this complex genetic condition.

Purpose of the Study:

  • To compile and analyze symptom prevalence in XP-CS patients.
  • To provide a comprehensive clinical description of the syndrome.
  • To inform clinical management strategies by leveraging data from XP and Cockayne syndrome.

Main Methods:

  • Conducted extensive literature searches to identify XP-CS patients.
  • Confirmed diagnoses using molecular or biochemical methods.
Keywords:
Cockayne syndromeDNA repair demyelinating disease (CNS)Developmental disordersLeukodystrophiesXeroderma pigmentosum

Related Experiment Videos

  • Summarized clinical features and generated statistics from identified patient data.

    • Main Results:

    • Identified 43 XP-CS patients, with 42 confirmed by molecular/biochemical methods.
    • XP-CS patients were classified into four complementation groups (XP-G, XP-D, XP-B, XP-F).
    • Clinical features resemble Cockayne syndrome, with a unique observation of lower cancer incidence compared to XP alone.

    Conclusions:

    • XP-CS exhibits overall homogeneity across complementation and severity groups.
    • Severely affected patients experience developmental delays and reduced lifespan.
    • The study provides a foundational dataset for understanding and managing XP-CS.